Log In
BCIQ
Print this Print this
 

Oxaydo, oxycodone (Aversion) (formerly Acurox, Oxecta)

  Manage Alerts
Collapse Summary General Information
Company Acura Pharmaceuticals Inc.
DescriptionOral immediate-release oxycodone tablets without niacin utilizing Aversion abuse-deterrent technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat acute and chronic moderate to severe pain; Treat moderate to severe pain
Regulatory Designation U.S. - Priority Review (Treat moderate to severe pain)
PartnerEgalet Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.0M

$5.0M

$15.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/08/2015

$20.0M

$5.0M

$15.0M

Get a free BioCentury trial today